Baseline Ex Vivo and Molecular Responses of Plasmodium falciparum Isolates to Piperaquine before Implementation of Dihydroartemisinin-Piperaquine in Senegal

Dihydroartemisinin-piperaquine, which was registered in 2017 in Senegal, is not currently used as the first-line treatment against uncomplicated malaria. A total of 6.6% to 17.1% of P. falciparum isolates collected in Dakar in 2013 to 2015 showed ex vivo-reduced susceptibility to piperaquine. Neithe...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Antimicrob Agents Chemother
Egile Nagusiak: Robert, Marie Gladys, Foguim Tsombeng, Francis, Gendrot, Mathieu, Diawara, Silman, Madamet, Marylin, Kounta, Mame Bou, Wade, Khalifa Ababacar, Fall, Mansour, Gueye, Mamadou Wague, Benoit, Nicolas, Nakoulima, Aminata, Bercion, Raymond, Amalvict, Rémy, Fall, Bécaye, Wade, Boubacar, Diatta, Bakary, Pradines, Bruno
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2019
Gaiak:
Epidemiology and Surveillance
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6496083/
https://ncbi.nlm.nih.gov/pubmed/30782997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02445-18
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak